Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrew D. Jenks
Observed names:
Andrew D Jenks,
Andrew Jenks,
Jenks, Andrew
Institutions:
Institute of Cancer Research,
Institute of Cancer Research
Observed institutions:
Institute of Cancer Research,
Simon Fraser University,
Wellcome Sanger Institute,
Institute of Cancer Research,
University of Westminster
ORCID:
0009-0005-1724-5412
Observed ORCID:
0009-0005-1724-5412
OpenAlex ID:
A5091543684
A high utility integrated map of the pig genome
2007
·
Sean J Humphray
, Carol E Scott
, et al.
·
Genome biology
·
162
PDF
Primary Cilia Mediate Diverse Kinase Inhibitor Resistance Mechanisms in Cancer
2018
·
Andrew D. Jenks
, Simon Vyse
, et al.
·
Cell Reports
·
112
PDF
Genetic inactivation of TRAF3 in canine and human B-cell lymphoma
2014
·
Kevin R. Bushell
, Yukyoung Kim
, et al.
·
Blood
·
89
A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia
2010
·
Miriam V. Dwek
, Andrew Jenks
, et al.
·
Clinica Chimica Acta
·
73
Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
2016
·
Jocelyn P. Wong
, Jason R. Todd
, et al.
·
Cell Reports
·
62
PDF
Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer
2021
·
Laura Pacini
, Andrew D. Jenks
, et al.
·
Cells
·
59
PDF
The proteomic landscape of soft tissue sarcomas
2023
·
Jessica Burns
, Christopher P. Wilding
, et al.
·
Nature Communications
·
46
PDF
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer
2021
·
Laura Pacini
, Andrew D Jenks
, et al.
·
Pharmacogenomics and Personalized Medicine
·
31
PDF
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
·
Clinical Cancer Research
·
13
Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall
2024
·
Madhumeeta Chadha
, Sara Iadecola
, et al.
·
Cancer Medicine
·
4
PDF
Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis
2022
·
Lukas Krasny
, Chris P Wilding
, et al.
·
Cancers
·
4
PDF
Dysregulated SASS6 expression promotes increased ciliogenesis and cell invasion phenotypes
2025
·
Eleanor Hargreaves
, Rebecca Collinson
, et al.
·
Life Science Alliance
·
3
PDF
Exploiting collateral sensitivity in the evolution of resistance to tyrosine kinase inhibitors in soft tissue sarcomas
2025
·
Mark L. Elms
, Andrew D. Jenks
, et al.
·
Communications Biology
·
2
PDF
Quantitative Determination of Primary Cilia Protein Distribution Using Immunofluorescence Staining and MATLAB Analysis
2021
·
Andrew Jenks
, Marc Fivaz
, et al.
·
BIO-PROTOCOL
·
1
Data from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Figure 3 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Supplementary Figure 4 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Figure 1 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Supplementary Figure 10 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Supplementary Figure 3 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Figure 5 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Figure 2 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Figure 4 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Supplementary Figure 1 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Supplementary Figure 2 from GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024
·
Silvia Stacchiotti
, Silvia Martini
, et al.
Show more works
View as search
Works count:
37
Citation count:
661
H-index:
9
I10-index:
9
Year
Topic
Type
